Vanese Clough, Author at Combinostics

BioCapital Europe 2023

Post author:Vanese Clough
Post published:March 9, 2023
Post category:Events
Post comments:0 Comments

At BioCapital Europe 2023, our CEO, Richard Hausmann, will discuss our company history and development of our cNeuro® suite.

cMRI Now Available Through TeraRecon’s Eureka Clinical AI Platform

Post author:Vanese Clough
Post published:March 7, 2023
Post category:News
Post comments:0 Comments

cMRI is now available through TeraRecon's Eureka Clinical AI platform, an AI solution for imaging analysis spanning neurology, oncology, pulmonology, and cardiology.

Read more about the article Imaging biomarkers play a crucial role in the development, approval, and use of disease-modifying drugs for Alzheimer’s disease

Imaging biomarkers play a crucial role in the development, approval, and use of disease-modifying drugs for Alzheimer’s disease

Post author:Vanese Clough
Post published:February 1, 2023
Post category:Blog
Post comments:0 Comments

Biomarkers, including imaging biomarkers, will be important for managing patients with Alzheimer's disease on disease-modifying drugs (DMD), such as Aduhelm and Leqembi, across the patient pathway.

ECR 2023

Post author:Vanese Clough
Post published:January 16, 2023
Post category:Events

Attending ECR 2023? Stop by our booth to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.

In radiology, AI has moved from a buzzword to a valuable tool: RSNA 2022

Post author:Vanese Clough
Post published:December 12, 2022
Post category:Blog

AI in radiology is here to stay. The next challenge is ensuring it’s seamlessly integrated into radiologists’ and technicians’ imaging workflows. Read about these and other takeaways from RSNA 2022 in this blog post from Richard Hausmann, CEO; Lennart Thurfjell, COO; and Greg Kingston, CMO.

Read more about the article Combinostics to Showcase Comprehensive Solutions for the Entire Patient Care Pathway of Neurological Disorders at RSNA

Combinostics to Showcase Comprehensive Solutions for the Entire Patient Care Pathway of Neurological Disorders at RSNA

Post author:Vanese Clough
Post published:November 23, 2022
Post category:News
Post comments:0 Comments

New and existing tools, including cPET, cARIA, and the Dementia Differential Analysis report, extend Combinostics’ solution beyond neurological image quantification and support end-to-end workflows.

Beyond neurological image quantification — RSNA 2022

Post author:Vanese Clough
Post published:November 15, 2022
Post category:Blog

As the only company providing a complete imaging AI solution that goes beyond neurological image quantification to support the entire patient care pathway, we’re excited to share our platform and solutions at RSNA 2022!

Fountain Health Announces Full Coverage On Neurological Imaging

Post author:Vanese Clough
Post published:November 15, 2022
Post category:News
Post comments:0 Comments

Fountain Health announces 100 percent coverage of Combinostics cMRI and cDSI. The company is now the first and only health insurance platform to provide complete coverage for the AI-enabled neurological imaging and decision support solutions.

Combinostics Adds Industry Experts to Leadership Team

Post author:Vanese Clough
Post published:November 8, 2022
Post category:News

Dr. Erik Post and Dr. Hans-Peter Huber have joined Combinostics as Group Chief Financial Officer (CFO) and Vice President of European Sales, respectively. Their contributions include considerable experience scaling software solutions.

RSNA 2022

Post author:Vanese Clough
Post published:November 3, 2022
Post category:Events
Post comments:0 Comments

Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.